村田 美幸 業績集

英文業績(2002年から現在まで)

IF (impact factor): 2019年ISI Journal Citation Reportsより

 

本数

IF合計

一編あたり

First author

6

29.634

4.939

Corresponding author

0

0

0

Second author

2

6.458

3.229

その他

23

90.503

3.935

英文全業績

31

126.595

4.084

 

  1. Fukutsu K, Murata M, Kikuchi K, Yoshida S, Noda K, Ishida S. ROCK1 mediates retinal glial cell migration promoted by acrolein. Front Med. 2021; 8: 717602
  2. Fukutsu K, Saito M, Noda K, Murata M, Kase S, Shiba R, Isogai N, Asano Y, Hanawa N, Dohke M, Kase M, Ishida S. A deep learning architecture for vascular area measurement in fundus images. Ophthalmology Science. 2021; 1: 100004
  3. Kanda A, Hirose I, Noda K, Murata M, Ishida S. Glucocorticoid-transactivated TSC22D3 attenuates hypoxia- and diabetes-induced Müller glial galectin-1 expression via HIF-1α destabilization. J Cell Mol Med. 2020; 24: 4589-4599
  4. Kikuchi K, Dong Z, Shinmei Y, Murata M, Kanda A, Noda K, Harada T, Ishida S. Cytoprotective effect of astaxanthin in a model of normal intraocular pressure glaucoma. J Ophthalmol. 2020; 2020: 9539681
  5. Kikuchi K, Murata M, Noda K, Kase S, Tagawa Y, Kageyama Y, Shinohara M, Sasase T, Ishida S. Diabetic Cataract in Spontaneously Diabetic Torii Fatty Rats. J Diabetes Res. 2020; 2020: 3058547
  6. Liu Y, Noda K, Murata M, Wu D, Kanda A, Ishida S. Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice. J Clin Med. 2020; 9: E2242
  7. Murata M, Noda K, Ishida S. Pathological role of unsaturated aldehyde acrolein in diabetic retinopathy. Front Immunol. 2020; 11: 589531
  8. Wu D, Kanda A, Liu Y, Noda K, Murata M, Ishida S. Involvement of Müller glial autoinduction of transforming growth factor-β in diabetic fibrovascular proliferation via glial-mesenchymal transition. Invest Ophthalmol Vis Sci. 2020; 61: 29
  9. Wu D, Noda K, Murata M, Liu Y, Kanda A, Ishida S. Regulation of Spermine Oxidase through Hypoxia-inducible Factor-1α Signaling in Retinal Glial Cells under Hypoxic Conditions. Invest Ophthalmol Vis Sci. 2020; 61: 52
  10. Murata M, Noda K, Yoshida S, Saito M, Fujiya A, Kanda A, Ishida S. Unsaturated aldehyde acrolein promotes retinal glial cell migration. Invest Ophthalmol Vis Sci. 2019; 60: 4425-4435
  11. Yoshida S, Murata M, Noda K, Matsuda T, Saito M, Saito W, Kanda A, Ishida S. Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells. Jpn J Ophthalmol. 2018; 62: 256-264
  12. Dong Y, Noda K, Murata M, Yoshida S, Saito W, Kanda A, Ishida S. Localization of Acrolein-lysine adduct in fibrovascular tissues of proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 111-117
  13. Kinoshita S, Ohguchi T, Noda K, Murata M, Yasueda S, Obata H, Matsunaga T, Fukushima T, Kanda A, Ishida S. Evaluation of the safety and tolerability of conjunctival ring for posterior segment of the eye. Curr Eye Res. 2017; 30: 1-6
  14. Matsuda T, Noda K, Murata M, Kawasaki A, Kanda A, Mashima Y, Ishida S. Vascular Adhesion Protein-1 Blockade Suppresses Ocular Inflammation after Retinal Laser Photocoagulation in Mice. Invest Ophthalmol Vis Sci. 2017; 58: 3254-3261
  15. Murata M, Noda K, Kawasaki A, Yoshida S, Dong Y, Saito M, Dong Z, Ando R, Mori S, Saito W, Kanda A, Ishida S. Soluble vascular adhesion protein-1 mediates spermine oxidation as semicarbazide-sensitive amine oxidase: possible role in proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 1674-1683
  16. Dong Y, Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Inafuku S, Tagawa Y, Ishizuka ET, Saito W, Murata M, Kanda A, Noda K, Ishida S. Phosphorylation of alphaB-crystallin in epiretinal membrane of human proliferative diabetic retinopathy. Int J Ophthalmol. 2016; 9: 1100-1105
  17. Dong Y, Kase S, Dong Z, Fukuhara J, Tagawa Y, Ishizuka ET, Murata M, Shinmei Y, Ohguchi T, Kanda A, Noda K, Ishida S. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium. Int J Mol Med. 2016; 38: 545-550
  18. Inafuku S, Noda K, Amano M, Ohashi T, Yoshizawa C, Saito W, Murata M, Kanda A, Nishimura S, Ishida Alteration of N-Glycan profiles in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015; 56: 5316-5322
  19. Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis. 2013; 19: 536-543
  20. Fukuhara J, Noda K, Murata M, Namba S, Kinoshita S, Dong Z, Ando R, Lennikov A, Kanda A, Ishida S. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2013; 54: 274-279
  21. Dong Z, Kase S, Ando R, Fukuhara J, Saito W, Kanda A, Murata M, Noda K, Ishida S. Alphab-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy. Retina. 2012; 32: 1190-1196
  22. Fukuhara J, Kase S, Noda K, Murata M, Noda M, Ando R, Dong Z, Kanda A, Ishida S. Immunolocalization of vascular adhesion protein-1 in human conjunctivaltumors. Ophthalmic Res. 2012; 48: 33-37
  23. Lennikov A, Kitaichi N, Noda K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Mizutani M, Fujikawa T, Itai A, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012; 18: 2586-2597
  24. Murata M, Noda K, Fukuhara J, Kanda A, Kase S, Saito W, Ozawa Y, Mochizuki S, Kimura S, Mashima Y, Okada Y, Ishida S. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53: 4055-62
  25. Ando R, Kase S, Ohashi T, Dong Z, Fukuhara J, Kanda A, Murata M, Noda K, Kitaichi N, Ishida S. Tissue factor expression in human pterygium. Mol Vis. 2011; 17: 63-69
  26. Itoh M, Murata T, Suzuki T, Shindoh M, Nakajima K, Imai K, Yoshida K. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene. 2006; 25: 1195-1204
  27. Itoh M, Murata T, Suzuki T, Shindoh M, Nakajima K, Imai K, Yoshida K. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. 2006; 25: 1195-1204
  28. Takahashi A, Higashino F, Aoyagi M, Yoshida K, Itoh M, Kobayashi M, Totsuka Y, Kohgo T, Shindoh M. E1AF degradation by a ubiquitin–proteasome pathway. Biochem Biophys Res Commun. 2005; 327: 575-580
  29. Iwasaki M, Nishikawa A, Akutagawa N, Fujimoto T, Teramoto M, Sakaguchi Y, Kato H, Itoh M, Yoshida K, Kudo R. E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen. Exp Cell Res. 2004; 299: 525-532
  30. Takahashi A, Higashino F, Aoyagi M, Yoshida K, Itoh M, Kyo S, Ohno T, Taira T, Ariga H, Nakajima K, Hatta M, Kobayashi M, Sano H, Kohgo T, Shindoh M. EWS/ETS fusions activate telomerase in Ewing's tumors. Cancer Res. 2003; 63: 8338-8344
  31. Itoh M, Adachi M, Yasui H, Takekawa M, Tanaka H, Imai K. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol. 2002; 16: 2382-2392
  32. Yoshida K, Nakayama K, Nagahama H, Harada T, Harada C, Imaki J, Matsuda A, Yamamoto K, Itoh M, Ohno S, Nakayama K. Involvement of p27 (KIP1) degradation by Skp2 in the regulation of proliferation in response to wounding of corneal epithelium. Invest Ophthalmol Vis Sci. 2002; 43: 364-370

※Itoh Mは村田美幸の旧姓名